Oncoclínicas do Brasil Serviços Médicos Future Growth
Future criteria checks 4/6
Oncoclínicas do Brasil Serviços Médicos is forecasted to grow earnings and revenue by 36.3% and 14.3% per annum respectively. EPS is expected to grow by 55.7%. Return on equity is forecast to be 16.4% in 3 years.
Earnings growth rate
EPS growth rate
|Healthcare earnings growth||43.4%|
|Revenue growth rate||14.3%|
|Future return on equity||16.4%|
|Last updated||14 Sep 2023|
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ONCO3's forecast earnings growth (36.3% per year) is above the savings rate (9.7%).
Earnings vs Market: ONCO3's earnings (36.3% per year) are forecast to grow faster than the BR market (12.3% per year).
High Growth Earnings: ONCO3's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ONCO3's revenue (14.3% per year) is forecast to grow faster than the BR market (6.4% per year).
High Growth Revenue: ONCO3's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ONCO3's Return on Equity is forecast to be low in 3 years time (16.4%).